Introduction Salivary gland carcinomas (SGC) are a highly heterogeneous group of human malignant tumors. Therapeutic options include surgical resection with adjuvant (chemo)radiotherapy as well as primary chemoradiation in advanced cases. However, disease recurrence or metastasis is frequently observed and no effective systemic therapies are currently available for RM-SGC.
No takes yet. Share an insight, caveat, or question.
Linxweiler et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: